C omplicating 7% to 10% of pregnancies, 1 preeclampsia, along with other hypertensive disorders of pregnancy, is a major contributor to maternal morbidity worldwide.
for preeclampsia. 23, 25 Despite these findings, the details of the role played by miR-210 in preeclampsia development remain largely unknown.
We performed bioinformatic analyses to predict target genes for miR-210 using 4 different programs, miRanda, TargetScan, miRBase, and PicTar, and found that potassium channel modulatory factor 1 (KCMF1) is one of the commonly predicted targets of miR-210. KCMF1 is a 42-kDa zinc finger protein comprising 381 amino acids with a high serine and threonine content. In 2001, KCMF1 was first mentioned to be potential in the regulation of potassium channels in Aplysia californica. 26 Shortly thereafter, KCMF1 was demonstrated to be downregulated in the Ewing sarcoma cell lines after the overexpression of CD99. 27 As a result of its upregulation by fibroblast growth factor receptor 2 signaling pathways in gastric cancer cells, KCMF1 was also named FIGC (basic fibroblast growth factor-induced gene in gastric cancer). 28 Interestingly, KCMF1 could enhance proliferation, migration, and invasion in epithelial cancers, especially in human and mouse pancreatic cancer. 26 However, the function of KCMF1 in the placenta remains unclear.
Based on the evidence noted above, we propose that miR-210 might regulate trophoblast cell invasion by targeting KCMF1 and that the pathway may play a role in the development of preeclampsia. To test this hypothesis, we used human trophoblast cell line, HTR8/SVneo, to investigate the mechanisms by which miR-210 exerts its function via the downregulation of KCMF1. We also explored the association of aberrant miR-210 and KCMF1 expression during abnormal placentation in preeclampsia.
Materials and Methods
Detailed Materials and Methods are provided in the online-only Data Supplement.
Patients and Placental Collection
Placental samples, delivered at 36 to 40 weeks, were collected from 15 severe preeclamptic patients and 26 normal pregnant women in the Department of Obstetrics and Gynecology, Peking University Third Hospital, China. Severe preeclampsia was defined according to the definition in Williams Obstetrics (23rd edition). Briefly, these patients had no history of pre-existing or chronic hypertension but exhibited systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg on ≥2 occasions, accompanying severe proteinuria (urinary protein excretion, ≥2 g/24 hours) after the 20th week of gestation. Patients with renal disease, transient hypertension in pregnancy, gestational diabetes mellitus, spontaneous abortion, intrauterine fetal death, fetal chromosomal or congenital abnormalities, or pregnancies conceived by fertility treatment were excluded from this study. The blood pressure of all patients returned to normal, and symptoms of proteinuria disappeared 6 weeks postpartum. The placentas were collected within 1 hour of cesarean birth, and specimens at the chorionic plate and basal plate were separately taken from the placenta disc near the position of umbilical cord insertion. The specimens were snap-frozen in liquid nitrogen and subjected to RNA extraction. The clinical characteristics of the patients enrolled in this study are summarized in the Table.
Statistical Analysis
All experiments were repeated ≥3 times. The results are expressed as the mean±SEM. Statistical analysis was performed using 1-way ANOVA or 2-sided Student t test, and differences with P<0.05 were considered statistically significant. All statistical analyses were performed using SPSS Statistics 22.0 for Windows (IBM, Armonk, NY).
Results

Expressions of KCMF1 and miR-210 Exhibited an Inverse Correlation in Placentas From Patients With Severe Preeclampsia
We examined KCMF1 and miR-210 expression levels in control and severe preeclamptic placentas using quantitative real-time polymerase chain reaction. Similar to our previous report, the level of miR-210 was significantly higher in the basal plate of severe preeclamptic placentas than in that of the normal pregnant controls ( Figure 1A ; P<0.05); however, its level in the chorionic plate seemed to be the same between the 2 groups ( Figure 1B) . The mRNA level of KCMF1was significantly lower in both the basal plate and the chorionic plate of severe preeclamptic placentas than in the corresponding control groups (Figure 1C and 1D; P<0.05). The KCMF1 protein level, as examined using Western blotting, also decreased in severe preeclamptic placentas ( Figure 1E and 1F) . Correlation analysis revealed an inverse correlation in miR-210 and KCMF1 expressions in the placental basal plate of the studied individuals ( Figure 1G ).
Localization of KCMF1 in Human Placenta
As shown in Figure 2 , immunohistochemistry revealed that KCMF1 localized in both the nucleus and cytoplasm in various subtypes of trophoblast cells, including villous cytotrophoblasts, column trophoblast cells, interstitial extravillous trophoblast cells, and endovascular trophoblast cells.
Validation of KCMF1 as the Direct Target of miR-210 in Human Trophoblast Cells
As shown in Figure 3A and 3B, the levels of both KCMF1 mRNA and protein were ≈40% and 60% lower in HTR8/ SVneo cells transfected with miR-210 mimics (miR-210) than the scramble control cells. Bioinformatics analysis reveals that KCMF1 is a potential target gene of miR-210. The seed sequence of miR-210 is complementary to the 554-to 561-nucleotide sequence of the 3′-UTR in KCMF1 mRNA. As shown in Figure 3C , we constructed a luciferase reporter vector by cloning a 240-bp DNA fragment, including binding site (BD) of the 3′-UTR in human KCMF1 mRNA downstream of the firefly luciferase reporter gene (the reporter vector was named BD-WT). A point mutation was incorporated into the binding sites of the 3′-UTR in the KCMF1 gene to generate BD-MUT reporter vector. As shown in Figure 3D , miR-210 mimics significantly reduced the relative luciferase activity of the BD-WT construct by ≈40% compared with the scramble control but did not influence the luciferase activity of the BD-MUT construct. These data strongly suggest that KCMF1 can be the target gene of miR-210 in human trophoblast cells and that the 554-to 561-nucleotide region of the 3′-UTR in the KCMF1 gene is the real binding site for miR-210.
Effects of miR-210 on Cell Invasion in HTR8/SV neo Cells
The effect of miR-210 on trophoblast cell invasion was further examined. Data of quantitative real-time polymerase chain reaction showed that the level of miR-210 increased to ≈400× that of the scramble control cells after miR-210 mimics transfection ( Figure 4A ) and decreased by ≈70% by miR-210 inhibitor compared with the inhibitor scramble control cells ( Figure 4B ). As shown in Figure 4C and 4D, transfection with miR-210 mimics or inhibitors could clearly repress or induce the cell invasiveness in HTR8/SVneo cells. To avoid any influence of cell growth on the results of the cell invasion assay, we treated the cells with mitomycin C when conducting the 
Overexpression of KCMF1 Rescued the InvasionRepressing Effect of miR-210 in HTR8/SVneo Cells
We performed a rescue experiment by transfecting HTR8/ SVneo cells with miR-210 together with a KCMF1-expressing construct (pKCMF1). Interestingly, the invasion-repressing effect of miR-210 was abrogated by the overexpressed KCMF1 ( Figure 5 ). The data indicate that miR-210 can mediate the invasiveness alterations in trophoblasts through an miR-210-KCMF1 pathway.
TNF-α Increases miR-210 Expression But Downregulates KCMF1
Tumor necrosis factor-α (TNF-α) has been reported as one of the regulators of miR-210 in other cell type, 29 and this inflammatory factor increased significantly in the fetal-maternal interface of patients with preeclampsia. [30] [31] [32] [33] [34] We treated HTR8/SVneo cells with recombinant human TNF-α and examined miR-210 and KCMF1 levels after 24 hours. As shown in Figure 6 , TNF-α significantly increased the expression of miR-210 by ≈1.8-fold over the control ( Figure 6A ), whereas it decreased KCMF1 mRNA and protein levels to 60% to 70% of the control ( Figure 6B and 6C) . The inverse change pattern of miR-210 and KCMF1 on TNF-α treatment in human trophoblast cells further indicated the functional correlation of the 2 molecules.
Discussion
Several investigators have reported that some microRNAs are irregularly expressed in preeclamptic placentas compared with normal placentas. [20] [21] [22] 25 Thus far, it has remained unclear how the deregulated microRNAs participate in the pathogenesis of preeclampsia. miR-210 is one of the significantly overexpressed small RNA in preeclamptic placentas. 21, 22, 25 Until now, functional studies on miR-210 have mainly focused on its role in cancer. The reasons that miR-210 attracted our attention in the study of placenta development were as follows: (1) In our previous study, we found that the levels of miR-210 increased in the plasma of preeclamptic individuals early in gestation (15-18 weeks), 25 indicating its possible participation in the cause of preeclampsia at early gestation. (2) Target prediction results show that KCMF1 is one of the possible targets of miR-210, and the predicted binding site in the 3′-UTR of KCMF1 mRNA is evolutionarily conserved from amphibians to humans. The evidence suggests that the regulation of KCMF1 by miR-210 might be conserved during evolution. (3) KCMF1 and miR-210 were all localized in various subtypes of human trophoblast cells. The KCMF1 and miR-210 expressions in the basal plate of preeclamptic placentas exhibited inverse association. The placental basal plate mainly consists of invasive interstitial trophoblast cells, indicating that miR-210-KCMF1 pathway may be involved in regulating trophoblast invasion.
Target exploration is critical for clarifying the mechanism of microRNAs. Several lines of evidence in this study prove that KCMF1 is a functional target of miR-210 in human trophoblasts. First, KCMF1 expression could be suppressed by miR-210 in HTR8/SVneo cells. Second, the luciferase report construct containing the putative miR-210-binding sequence in KCMF1 mRNA was specifically responsive to miR-210 overexpression, as shown by inhibition of the luciferase activity. The inhibitory effect of miR-210 on the luciferase activity was abolished on mutation of the binding sites paired by the seed sequence of miR-210. Third, functional study in HTR8/ SVneo cells demonstrated an invasion-prohibited effect of miR-210. Importantly, the ectopic overexpression of KCMF1 could well abrogate the invasion-repressing effect of miR-210. These findings proved that KCMF1 is a critical miR-210 target, at least participating in mediating the invasion-modulating role of miR-210 in human trophoblast cells. The invasion-repressing effect of miR-210 that was observed in HTR8/SVneo cells could, at least in part, result from the interference with the signaling mediated by KCMF1. Abnormal placental development, especially the shallow invasion of trophoblasts into the decidual stroma and spiral arteries during early gestation, has been generally accepted as the major causal factor for preeclampsia. 35 The findings in the present study provided evidence to indicate the involvement of miR-210-KCMF1 pathway in the shallow trophoblast cell invasion in preeclamptic placenta.
Functional studies of miR-210 have been largely performed in cancer cells, and the data demonstrated its participation in regulating various cell behaviors, including proliferation, migration, apoptosis, differentiation, DNA repair, and cell metabolism. 36, 37 Interestingly, the function of miR-210 could be opposite in different cell types being tested. For insistence, miR-210 could target proteins that are crucial for the cell cycle, such as E2F transcription factor 3, 17,38 fibroblast growth factor receptor-like 1, 39, 40 or homeobox A1, 40 resulting in the inhibition of cell growth in epithelial cells, 38 human esophageal squamous cell carcinoma HE3 cells, 39 or FaDu cells. 39, 40 However, it had growth-stimulating effect in HCT116 Dicere 14 Human placental trophoblast cells possess similar properties to tumor cells in terms of proliferation and invasion, although their behaviors are temporally and spatially restricted during pregnancy. 41 We did not find any influence of miR-210 on cell proliferation in HTR8/SVneo cells. Our finding of the inhibition on human trophoblast cell invasion by miR-210 was consistent with the recent reports by Zhang et al 24 and Anton et al 23 but were contradictory to the observations in endothelial cells 18 and renal carcinoma cells. 42 It is most likely that miR-210 works in a unique way in human trophoblast cells, different from that in cancer cells. Considering the fact that 1 microRNA may regulate diverse targets in different cellular contexts, experimental validation of miR-210 targets in trophoblast cells remains to be The mechanism of miR-210 upregulation in the preeclamptic placenta remains elusive. The vascular remodeling at the failed placental site has been the target of intense scrutiny in studies of preeclampsia. It seems that the remodeling of spiral arteries is largely a result of cytotrophoblast invasion. The cellular control of trophoblast invasion depends on interactions between the maternal decidua and the fetal trophoblast, and immune maladaptation is an important factor that contributes to the inadequate invasion of cytotrophoblasts into the uterine decidua. 43 Local oxygen tension and immune-or inflammatorymediated interactions are primary determinants of the process. 44 Several cytokines, such as interleukin-2, interferon-γ, and TNF-α, are well-known mediators of immune maladaptation in preeclampsia. 30 ,45 TNF-α has been shown to decrease the motility of HTR-8/SVneo cells in vitro 31 and to negatively affect the migration and invasion of trophoblasts. It has been reported that TNF-α stimulates reactive oxygen species production by several mechanisms, including direct toxicity and its effects on mitochondrial function. 46, 47 In addition, reactive oxygen species generation by diverse sources induces miR-210 expression in adipose-derived stem cells via the platelet-derived growth factor receptor-b, Akt, and elk-related tyrosine kinase pathways. Transcription of miR-210 is regulated by nuclear factor-κB and Elk1. 48 Kopriva et al 49 observed that toll-like receptor 3 activation induces placental miR-210 through hypoxia-inducible factor-1α and the nuclear factor-κB-p50 pathway, leading to a decrease in signal transducer and activator of transcription 6, interleukin-4 induced, and interelukin-4 levels, which may contribute to the development of preeclampsia. In this study, we found that TNF-α significantly increased the expression of miR-210 in HTR-8/ SVneo cells, which is similar to the observation of Kagiya et al 29 in murine macrophage cell line, RAW264.7 cells. Meanwhile, the KCMF1 expression was downregulated on TNF-α treatment. We assume that the increased miR-210-KCMF1 pathway may also be involved in the immune maladaptation at the fetalmaternal interface during the occurrence of preeclampsia.
In general, this study extends our knowledge on the functions of miR-210 and KCMF1 in the human placenta. Our findings provide new evidence that aberrantly expressed miR-210, via downregulating KCMF1, may play an important role in the development of preeclampsia.
Perspectives
Additional in vivo studies using miR-210 transgene animals are warranted to comprehensively understand the roles of the aberrantly expressed miR-210 in the onset and progression of preeclampsia. 
